Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh sleep quality index factor scoring model

Journal of Women's Health

Volumn 18, Issue 9, 2009, Pages 1355-1360

  Yurcheshen, Michael E ^a,e   Guttuso, Thomas ^b   McDermott, Michael ^a   Holloway, Robert G ^c   Perlis, Michael ^d  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG WITHDRAWAL; FEMALE; HEART PALPITATION; HOT FLUSH; HUMAN; MENOPAUSE; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP; SLEEP PATTERN; SOMNOLENCE; TREATMENT OUTCOME;

ADULT; AMINES; ANALGESICS; COHORT STUDIES; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; SLEEP; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 70349210421     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.1257     Document Type: Article

References (31)

1. Kravitz H, Ganz P, Bromberger J, et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19-28.
2. Newman AB, Enright PL, Manolio TA, et al. Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: The Cardiovascular Health Study. J Am Geriatr Soc 1997;45:1-7.
3. Moline M, Broch L, Zak R. Sleep in women across the life cycle from adulthood through menopause. Med Clin North Am 2004;88:705-736.
4. Young T, Rabago D, Zgierska A, et al. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin sleep cohort study. Sleep 2003;26:667-672.
5. Sharkey KM, Bearpark HM, Acebo C, et al. Effects of menopausal status on sleep in midlife women. Behav Sleep Med 2003;1:69-80.
6. Shaver JLF, Giblin E, Paulsen V. Sleep quality subtypes in midlife women. Sleep 1991;14:18-23.
7. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
8. Dorsey CM, Lee KA, Scharf MB. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study. Clin Therap 2004;26:1578-1586.
9. Hajak G, Muller WE, Wittchen HU, et al. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 2003;98:1371-1378.
10. Kerwin J, Gordon P, Senf J. The variable response of women with menopausal hot flashes when treated with sertraline. Menopause 2007;14:841-845.
11. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280:1831-1836.
12. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-1842.
13. Guttuso T, Jr, Kurlan R, McDermott MP, et al. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337-345.
14. Reddy SY, Warner H, Guttuso T, et al. Gabapentin, estrogen, and placebo for treating hot flushes. Obstet Gynecol 2006; 108:41-48.
15. Buysse DJ, Reynolds CF, 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
16. Cole JC, Motivala SJ, Buysse DJ, et al. Validation of a 3-factor scoring model for the Pittsburgh Sleep Quality Index in older adults. Sleep 2006;29:112-116.
17. Beale EML, Little RJA. Missing values in multivariate analysis. J R Statist Soc B 1975;37:129-145.
18. Little RJA, Rubin DB. Statistical analysis with missing data, 2nd ed. New York: Wiley, 2002.
19. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer-Verlag, 2000.
20. Saletu-Zyhlarz G, Anderer P, Gruber G, et al. Insomnia during menopause: sleep laboratory studies on insomnia associated with postmenopausal syndrome and hormone replacement therapy. In: Attarian HP, ed. Sleep disorders in women: A guide to practical management. Totowa, NJ: Humana Press; 2006:225-250.
21. Baker A, Simpson S, Dawson D. Sleep disruption and mood changes associated with menopause. J Psychosom Res 1997;43:359-369.
22. Regestein QR, Friebely J, Shifren JL, et al. Self-reported sleep in postmenopausal women. Menopause 2004;1:198-207.
23. Shaver J, Giblin E, Lentz M, et al. Sleep patterns and stability in perimenopausal women. Sleep 1998;11:556-561.
24. Foldvary-Schaefer N, De Leon Sanchez I, Karafa M, et al. Gabapentin increases slow-wave sleep in normal adults. Epilepsia 2002;43:1493-1497.
25. Placidi F. Effect of anticonvulsants on nocturnal sleep in epilepsy. Neurology 2000;54:S25-S32.
26. Physicians' Desk Reference. Montvale, NJ: Thomson; 2008: 2466.
27. Wesstrom J, Nilsson S, Sundstrom-Poromaa I, et al. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric 2008;11:422-428.
28. Freedman RR, Roehrs TA. Sleep disturbance in menopause. Menopause 2007;14:826-829.
29. Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002;59:1573-1579.
30. Stephani A, Spadoni F, Bernardi G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology 1998;37:83-91.
31. Gee NS, Brown JP, Dissanayake VU, et al. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996; 271:5768-5776.